EcoDrugPlus

Tubulin Beta 1 Class Vi

Ensembl ID : ENSOCUG00000029727
Gene Symbol: TUBB1
2 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSOCUG00000009827
Gene Symbol: TUBB2B
3 Cross references
279 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSOCUG00000027557
Gene Symbol: TUBB3
2 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSOCUG00000024997
Gene Symbol: TUBB4A
3 Cross references
94 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSOCUG00000002187
Gene Symbol: TUBB
3 Cross references
348 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSOCUG00000001138
Gene Symbol: TP53
3 Cross references
252 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOCUG00000009965
Gene Symbol: TYR
3 Cross references
266 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSOCUG00000014816
Gene Symbol: TYK2
2 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSOCUG00000008969
Gene Symbol: TIE1
2 Cross references
203 Possible Orthologues:

Utrophin

Ensembl ID : ENSOCUG00000015080
Gene Symbol: UTRN
2 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSOCUG00000011610
Gene Symbol: VEGFA
2 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSOCUG00000027507
Gene Symbol: VDR
2 Cross references
458 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).